DX
Daxor Corporation
DXR · NASDAQ
$11.45 +1.78% (+$0.20)
1M +17.20%
Market Cap $67.9M
P/E Ratio 7.40x
Div. Yield -
ROE 21.69%
Bulios Fair Price
$5.89
48.6% downside
Trenutna cena
$11.45
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica DXR trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
4/9Valuation
86 /100
Cheap PEG 0.00x
P/E 7.40x
P/B 1.48x
Growth
100 /100
Growing Book val. growth 16.57%
EPS growth 45.29%
FCF growth N/A
Profitability
65 /100
Moderate Op. margin 1,824.65%
Gross margin 37.49%
FCF margin 120.06%
Quality
85 /100
Excellent ROA 19.93%
ROIC 19.96%
Asset turnover 0.01x
Debt
100 /100
Low Net debt/EBITDA 0.01x
Debt/Equity 0.00x
Int. coverage 575.44x
Stability
16 /100
Unstable EPS volatility 914.46%
Beta 0.26x
Profitable years 5
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o DXR
Online
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Michael Richard Feldschuh
Employees
37
Headquarters
Oak Ridge
Prihajajoči dogodki
10 MAR.
Earnings
Upcoming earnings report